<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03398213</url>
  </required_header>
  <id_info>
    <org_study_id>0108-17-BNZ</org_study_id>
    <nct_id>NCT03398213</nct_id>
  </id_info>
  <brief_title>Acupuncture Treatment of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation</brief_title>
  <official_title>Acupuncture Efficacy in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease During Hospitalization: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic obstructive pulmonary disease (COPD) is a major health problem. Acute exacerbations
      are a health-care burden involving frequent hospitalizations and elevated costs. They have
      effective therapies with significant side effects. Acupuncture has been shown to reduce
      dyspnea and other COPD-related symptoms. The investigators will compare the efficacy and
      safety of the addition of true acupuncture to usual care with both sham-acupressure added to
      usual care and usual care only for the treatment of acute exacerbations of COPD among
      inpatients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an assessor-blinded randomized controlled trial in the setting of a tertiary academic
      medical center in Israel. Patients with clinical diagnosis of acute exacerbation of COPD will
      be randomized to either usual care only, usual care with true acupuncture or usual care with
      sham-acupressure. The primary outcome will be clinical improvement as measured by validated
      diaries. Secondary outcomes will include duration of hospitalization and improvement of
      objective features (oxygen saturation, respiratory rate, blood gases). Acupuncture-related
      side effects will be evaluated by the validated Acupuncture Adverse Events (AcupAE)
      questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2017</start_date>
  <completion_date type="Anticipated">December 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical improvement</measure>
    <time_frame>At baseline, day 1, day 2, day 3, and day 4 of the study</time_frame>
    <description>EXAcerbations of Chronic pulmonary disease Patient-Reported Outcome (EXACT-PRO) diary: this scale quantifies and measures symptoms of COPD exacerbation on a 0-56 scale (patients answer 14 questions rated from 0 to 4 each). The total value will be reported and higher values represent worse prognosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>Through study completion, an average of 1 week</time_frame>
    <description>Days of hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbon dioxide partial pressure (pCO2)</measure>
    <time_frame>At baseline, day 1, day 2, day 3, and day 4 of the study</time_frame>
    <description>pCO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Power of hydrogen (pH)</measure>
    <time_frame>At baseline, day 1, day 2, day 3, and day 4 of the study</time_frame>
    <description>pH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>At baseline, day 1, day 2, day 3, and day 4 of the study</time_frame>
    <description>Respiratory rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>At baseline, day 1, day 2, day 3, and day 4 of the study</time_frame>
    <description>Oxygen saturation</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acupuncture for treatment of COPD exacerbation + standard conventional care for COPD exacerbation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham procedure</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Ear stimulation with plaster + standard conventional care for COPD exacerbation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard conventional care for COPD exacerbation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture</description>
    <arm_group_label>Acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham procedure</intervention_name>
    <description>Ear stimulation with plaster</description>
    <arm_group_label>Sham procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous diagnosis of COPD

          -  Clinical diagnosis of acute exacerbation of COPD

          -  Informed consent

        Exclusion Criteria:

          -  Hemodynamic instability

          -  Platelet count &lt; 20 x 10^9/L
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elad Schiff, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bnai Zion Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elad Schiff, M.D.</last_name>
    <phone>972-506267243</phone>
    <email>elad.schiff@b-zion.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ilana Levy, M.D.</last_name>
    <phone>972-525086128</phone>
    <email>ilana.e.levy@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <state>Golomb 47</state>
        <zip>3104802</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilana Levy, M.D.</last_name>
      <phone>972-525086128</phone>
      <email>ilana.e.levy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ELAD SCHIFF</last_name>
      <phone>972506267243</phone>
      <email>ESCHIFF@BEZEQINT.NET</email>
    </contact>
    <investigator>
      <last_name>ELAD SCHIFF, PI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>December 31, 2017</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>two years within trial completion</ipd_time_frame>
    <ipd_access_criteria>in peer reviewed journal</ipd_access_criteria>
  </patient_data>
  <pending_results>
    <submitted>June 23, 2020</submitted>
    <returned>July 10, 2020</returned>
    <submitted>July 21, 2020</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

